InvestorsHub Logo
Followers 7
Posts 301
Boards Moderated 0
Alias Born 03/31/2016

Re: None

Tuesday, 06/08/2021 7:03:26 AM

Tuesday, June 08, 2021 7:03:26 AM

Post# of 461803
Anavex Life Sciences Announces Exceeding of Enrollment Target for the Precision Medicine ANAVEX®2-73 (blarcamesine) Phase 2b/3 Clinical Trial in Patients with Alzheimer’s Disease


https://www.globenewswire.com/news-release/2021/06/08/2243439/29248/en/Anavex-Life-Sciences-Announces-Exceeding-of-Enrollment-Target-for-the-Precision-Medicine-ANAVEX-2-73-blarcamesine-Phase-2b-3-Clinical-Trial-in-Patients-with-Alzheimer-s-Disease.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News